Top Tweets for #CART22

over 4 years ago

During #CART22, the #LymphomaHub was pleased to speak with @MediHumdani, @MedicalCollege. We asked, CAR-T or stem cell transplant for second-line treatment of aggressive B-cell non-Hodgkin #lymphoma? 👉 https://t.co/Zj7mU8QDSU 👈 #lymsm #lymphoma #nHL

lymphomahub's tweet photo. During #CART22, the #LymphomaHub was pleased to speak with @MediHumdani, @MedicalCollege. We asked, CAR-T or stem cell transplant for second-line treatment of aggressive B-cell non-Hodgkin #lymphoma?

👉 https://t.co/Zj7mU8QDSU 👈

#lymsm #lymphoma #nHL https://t.co/9oetjmxrND

0

6

2

1

0

coimmune @CoImmune

over 4 years ago

This article by @HemOncToday covers data from CAR-CIK cell research in #leukemia that was presented by @ChiaraFMagnani at #CART22 organized by @TheEBMT and @EHA_Hematology: https://t.co/BYEjJ79hPp

0

2

0

over 4 years ago

Setting up and running a CAR-T unit: patient's perspective | @LornaWarwick of @knowyournodes shares some insights. Watch her interview now: 👉https://t.co/GkqVLlz3xq👈 @TheEBMT @EHA_Hematology #CART22 #CARTtherapy #ImmunoOnc #HemOnc #CART #tcellrx #Lymphoma #LymSM

0

6

4

0

over 4 years ago

📣 The most exciting updates shared at #CART22 📣 ⬇️⬇️⬇️ https://t.co/7dccvukIvu @TheEBMT @EHA_Hematology #CARTtherapy #CART #tcellrx #ImmunoOnc #HemOnc #MMsm #LYMsm #ALLsm #CARTcell #CTSM #TrialUpdate

0

2

1

0

over 4 years ago

The nurse's role in CAR-T therapy | @michellekenyon5 shares her thoughts: 👉https://t.co/6gtfUXTVm9👈 @TheEBMT @EHA_Hematology #CART22 #CARTtherapy #CARTcell #tcellrx #ImmunoOnc #HemOnc

0

5

2

0

over 4 years ago

Exploring the applications of CAR-Ts beyond hematology and oncology w/ Michael Hudecek (@Uni_WUE): 👉https://t.co/ieyeB6YeDN👈 @TheEBMT @EHA_Hematology #CART22 #CART #CARTcell #CARTtherapy #ImmunoOnc #HemOnc #tcellrx #IDTwitter

0

3

4

0

over 4 years ago

Find the most important updates in #CART from #CART22 in our new feature 💉 👉https://t.co/8IZYUhNlC9👈 Ft. exclusive insights from Michael Hudecek , @Mohty_EBMT, Ulrich Jäger & Michael Schmitt 🔎 @TheEBMT @EHA_Hematology #CARTtherapy #CARTcell #tcellrx #ImmunoOnc #HemOnc

0

8

5

1

0

over 4 years ago

👀 During #CART22, the Lymphoma Hub spoke with @gilles_salles, @MSKCancerCenter. We asked, When is CAR-T a good option for patients with follicular and marginal zone #lymphoma? 👉 https://t.co/uVXKPoPKtP 👈 #lymsm #FL #MZL

lymphomahub's tweet photo. 👀 During #CART22, the Lymphoma Hub spoke with @gilles_salles, @MSKCancerCenter. We asked, When is CAR-T a good option for patients with follicular and marginal zone #lymphoma?

👉 https://t.co/uVXKPoPKtP 👈

#lymsm #FL #MZL https://t.co/GIarP2APaO

0

3

0

over 4 years ago

📹 During #CART22 the Lymphoma Hub was pleased to speak with Julio Delgado, Hospital Clínic de Barcelona. We asked, How might CAR T-cells change the treatment landscape for patients with #CLL? 👉 https://t.co/Vv1iyLI9dU 👈 #leusm #leukemia #lymsm

lymphomahub's tweet photo. 📹 During #CART22 the Lymphoma Hub was pleased to speak with Julio Delgado, Hospital Clínic de Barcelona. We asked, How might CAR T-cells change the treatment landscape for patients with #CLL?

👉 https://t.co/Vv1iyLI9dU 👈

#leusm #leukemia #lymsm https://t.co/LkwfOTnibu

0

2

1

0

over 4 years ago

Minimizing the costs of CAR-T manufacturing | Ulrike Koehl of @UniLeipzig shares her thoughts. Watch now: 👉https://t.co/nrOedx2GUm👈 @TheEBMT @EHA_Hematology #CART22 #CARTtherapy #ImmunoOnc #HemOnc #CART #tcellrx

0

5

1

0

over 4 years ago

🚨 Missed #CART22? Don’t worry! Find the most important updates in #CARTtherapy in #HemOnc in our new feature 💉🩸 👉https://t.co/CWCeae8j4N👈 @TheEBMT @EHA_Hematology #ImmunoOnc #CART #CARTcell #tcellrx #MMsm #LYMsm #ALLsm #CTSM #TrialUpdate

0

2

3

0

over 4 years ago

Raffaella Greco of @SanRaffaeleMI talks on managing patients treated with CAR-Ts during the COVID-19 pandemic. Watch: 👉https://t.co/e2MlfbhVRp👈 @TheEBMT @EHA_Hematology #CART22 #CARTtherapy #ImmunoOnc #HemOnc #CART #tcellrx

0

5

0

over 4 years ago

CAR-T therapy in second-line for NHL: ZUMA-7, TRANSFORM & BELINDA - @AnnaSureda5 shares her thoughts. Watch her interview now: 👉https://t.co/56lLXk5Sxb👈 @TheEBMT @EHA_Hematology #CART22 #Lymphoma #LymSM #TrialUpdates #CARTtherapy #ImmunoOnc #HemOnc #CART #tcellrx

0

7

3

0

EBMT

@TheEBMT

over 4 years ago

If you missed a session from the #EBMT-@EHA_Hematology 4th European CAR T-cell Meeting or would like to watch a presentation again, you have until next Saturday, 12 March at 23:59 CET to view it on-demand in the #CART22 virtual event platform. Log in at ⬇️ https://t.co/yGGhQdVyW3

TheEBMT's tweet photo. If you missed a session from the #EBMT-@EHA_Hematology 4th European CAR T-cell Meeting or would like to watch a presentation again, you have until next Saturday, 12 March at 23:59 CET to view it on-demand in the #CART22 virtual event platform. Log in at ⬇️
https://t.co/yGGhQdVyW3 https://t.co/yAOkUfMmyb

0

3

1

0